Browse all articles >
Sorafenib vs. Lenvatinib in advanced hepatocellular carcinoma
Identification of KCTD17 as a RAS stabilizer in hepatocellular carcinoma
Steatotic liver disease in chronic hepatitis C related hepatocellular carcinoma: Inflictor or bystander?
Current evidence and the potential role of proton beam therapy for hepatocellular carcinoma2023 October;29(4)
Recent advances in the management of hepatocellular carcinoma2024 January;30(1)